Parotid-sparing IMRT for Nasopharyngeal Cancer

NCT02149641 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2014-05-29

No results posted yet for this study

Summary

In the treatment of nasopharyngeal cancers, to determine the incidence of high grade (≥G2) subjective xerostomia at 1 year.

Conditions

  • Nasopharyngeal Cancers
  • Intensity Modulated Radiotherapy With Chemotherapy

Interventions

RADIATION

Intensity modulated radiotherapy with chemotherapy

Sponsors & Collaborators

  • Royal Marsden NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Christopher M Nutting, FRCR · Royal Marsden NHS Foundation Trust

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2011-04-30
Completion
2012-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02149641 on ClinicalTrials.gov